Drug Combination Reduces Number of Colorectal Polyps in Patients with Hereditary Cancer Syndrome

People with, FAP, an inherited condition that greatly increases their risk of gastrointestinal cancer who took a combination of erlotinib (Tarceva) and sulindac (Aflodac) saw a decrease in the number of precancerous lesions in the colon and rectum.

Cancer Currents: An NCI Cancer Research Blog